Kathy Gately

2.6k citations

79 papers · 1.8k indexed · h-index 24

Impact in

Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Oncology top 5%

Papers in

Cancer Research 21
- Cancer Genomics and Diagnostics 6
- Cancer, Hypoxia, and Metabolism 6
- NF-κB Signaling Pathways 6
Oncology 29

Co-authors: Kenneth J. O’Byrne Susan Heavey Anne‐Marie Baird Martin P. Barr Nael Al-Sarraf Stephen P. Finn P. Godwin Julie Lucey
Journals: Lung Cancer (11 papers)Journal of Thoracic Oncology (6 papers)Journal of Clinical Oncology (6 papers)Cancers (3 papers)Clinical Lung Cancer (3 papers)
Partner nations: Ireland Australia United Kingdom

In The Last Decade

Kathy Gately

78 papers receiving 1.8k citations

Peers

Countries citing papers authored by Kathy Gately

Since Specialization

Citations

This map shows the geographic impact of Kathy Gately's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathy Gately with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathy Gately more than expected).

Fields of papers citing papers by Kathy Gately

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathy Gately. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathy Gately. The network helps show where Kathy Gately may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Kathy Gately, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathy Gately Line = papers co-authored together Kathy Gately links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer Molecular Oncology ·Cheryl Morris, Nathan Schwery, Mark P. Ward, Sinéad Hurley, Sandra Maria Delgado Cadena, Abigail Gualito Atanasio, Stephen P. Finn, Gerard J. Fitzmaurice, John O’Leary, Sharon O’Toole, Lorraine O’Driscoll, Kathy Gately	2024	5
2	Treatment Strategies for KRAS-Mutated Non-Small-Cell Lung Cancer Cancers ·E O'Sullivan, Jürgen Otten, Brian E. Henderson, Stephen P. Finn, Steven G. Gray, Kathy Gately	2023	47
3	Co-Targeting PIM Kinase and PI3K/mTOR in NSCLC Cancers ·Gillian Moore, Evelyn Worboys, Keith E Hainan, Lauren Brady, Siobhan Nicholson, Ronan Ryan, Katie E. O’Sullivan, Kenneth J. O’Byrne, Carmen Blanco‐Aparicio, Sinéad Cuffe, Michael F. O‘Neill, Susan Heavey, Stephen P. Finn, Kathy Gately	2021	8
4	Vaping and lung cancer – A review of current data and recommendations Lung Cancer ·Dara Bracken‐Clarke, 汪尧进, Anne‐Marie Baird, Paul Buchanan, Kathy Gately, Sinéad Cuffe, Stephen P. Finn	2021	79
5	Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells Cancers ·Patricia Gaule, Nupur Mukherjee, B. Corkery, Alex J. Eustace, Kathy Gately, Sandra Roche, Robert O’Connor, Kenneth J. O’Byrne, Naomi Walsh, Michael J. Duffy, John Crown, Norma O’Donovan	2019	19
6	Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC Lung Cancer ·H.-P. Jachertz, Dr.Ismat Ullah, Martin P. Barr, Х. А. Перес-Пераса, Susan Heavey, P. Godwin, Steven G. Gray, P. Patte, Stephen P. Finn, Kathy Gately, Anthony M. Davies, Erik W. Thompson, Derek J. Richard, Kenneth J. O’Byrne, Mark N. Adams, Anne‐Marie Baird	2019	26
7	Current perspectives on targeting PIM kinases to overcome mechanisms of drug resistance and immune evasion in cancer Pharmacology & Therapeutics ·Vishnu Priya V., 何立波, Nathalie Simon, Susan Heavey, Sinéad Cuffe, Stephen P. Finn, Gillian Moore, Kathy Gately	2019	28
8	IHC-based subcellular quantification provides new insights into prognostic relevance of FLIP and procaspase-8 in non-small-cell lung cancer Cell Death Discovery ·Ryan Hutchinson, Helen G. Coleman, Kathy Gately, Vincent Young, Siobhan Nicholson, Robert Cummins, Elaine W. Kay, Seán O. Hynes, Philip D. Dunne, Suzana Andreoli Marques Ezquina, Peter W. Hamilton, Darragh G. McArt, Daniel B. Longley	2017	5
9	P1.02-065 Elucidating the Role of PIM Kinase and Its Therapeutic Potential in NSCLC Journal of Thoracic Oncology ·Gillian Moore, Susan Heavey, Evelyn Worboys, Lauren Brady, Kenneth J. O’Byrne, Stephen P. Finn, Sinéad Cuffe, Michael F. O‘Neill, Kathy Gately	2017	1
10	Expression of CDCA3 Is a Prognostic Biomarker and Potential Therapeutic Target in Non–Small Cell Lung Cancer Journal of Thoracic Oncology ·Mark N. Adams, Joshua T. Burgess, Yaowu He, Kathy Gately, Cameron Snell, Shudong Zhang, John D. Hooper, Derek J. Richard, Kenneth J. O’Byrne	2017	63
11	Activation and cleavage of SASH1 by caspase-3 mediates an apoptotic response QUT ePrints (Queensland University of Technology) ·Joshua T. Burgess, Emma Bolderson, Mark N. Adams, Anne‐Marie Baird, Shudong Zhang, Kathy Gately, Kazuo Umezawa, Kenneth J. O’Byrne, Derek J. Richard	2016	2
12	Tumour islet Foxp3+ T-cell infiltration predicts poor outcome in nonsmall cell lung cancer QUT ePrints (Queensland University of Technology) ·Dermot S. O’Callaghan, Elton Rexhepaj, Kathy Gately, Linda Coate, David Delaney, Dearbhaile M. O’Donnell, Elaine W. Kay, Finbarr O’Connell, William M. Gallagher, Kenneth J. O’Byrne	2015	3
13	Mutational analysis of the insulin‑like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients QUT ePrints (Queensland University of Technology) ·Kathy Gately, Shong-Ling Lin, Steven G. Gray, Derek W. Morris, Aiden Corvin, Prerna Tewari, Kenneth J. O’Byrne	2015	1
14	Abnormal levels of heterogeneous nuclear ribonucleoprotein A2B1 (hnRNPA2B1) in tumour tissue and blood samples from patients diagnosed with lung cancer Molecular BioSystems ·Paul Dowling, 浩輔西村, Annemarie Larkin, Michael Henry, Paula Meleady, Kathy Gately, Kenneth J. O’Byrne, Martin P. Barr, Vincent J. Lynch, Jo Ballot, John Crown, M. Moriarty, E O’Brien, Ross Morgan, Martin Clynes	2014	26
15	The establishment of an ISO compliant cancer biobank for Jordan and its neighboring countries through knowledge transfer and training Arrow@dit (Dublin Institute of Technology) ·Martin P. Barr, Lina Souan, S. Shenoy, Jeanette Müller, RongBo WANG, Florian Braune, ShyamK Shrivastava, Geneeva Villamor, Abigail Johnson, Swati Saha, F. Kirchner, Kathy Gately, Daniel Mareček, Kenneth J. O’Byrne, Maher A. Sughayer	2014	1
16	RanGTPase: A Candidate for Myc-Mediated Cancer Progression JNCI Journal of the National Cancer Institute ·QI Shuang-ji, Vignesh Gunasekharan, Junting Sai, Shudong Zhang, Angela Platt‐Higgins, Kathy Gately, Kenneth J. O’Byrne, Dean A. Fennell, Patrick G. Johnston, Philip S. Rudland, Mohamed El‐Tanani	2013	3
17	Prognostic and therapeutic relevance of FLIP and procaspase-8 overexpression in non-small cell lung cancer Cell Death and Disease ·Joel S. Riley, Ryan Hutchinson, Darragh G. McArt, Nyree Crawford, Caitriona Holohan, Sushruti Tanksali, Sandra Van Schaeybroeck, Manuel Salto‐Tellez, P. G. Johnston, Dean A. Fennell, Kathy Gately, Kenneth J. O’Byrne, Robert Cummins, E. Kay, Peter Hamilton, HexCam, DB Longley	2013	1
18	Surgical resection for non-small cell lung cancer: clinical features and outcomes for a consecutive series at an Irish tertiary referral centre Irish Journal of Medical Science (1971 -) ·Bassel Al-Alao, Dermot S. O’Callaghan, Kathy Gately, Siobhan Nicholson, Linda Coate, Fiona O’Connell, Jerzy Greblicki, Kenneth J. O’Byrne, Vincent Young	2012	4
19	PARP inhibition induces BAX/BAK‐independent synthetic lethality of BRCA1‐deficient non‐small cell lung cancer The Journal of Pathology ·Zheyu Du, Kienan I. Savage, Jaine K. Blayney, Kholada Sa’diyah, Kathy Gately, Keith M. Kerr, Michael Sheaff, Ken Arthur, Derek J. Richard, Peter W. Hamilton, Jacqueline A. James, Kenneth J. O’Byrne, D. Paul Harkin, Jennifer E. Quinn, Dean A. Fennell	2011	29
20	Predictors of acute renal failure requiring renal replacement therapy post cardiac surgery in patients with preoperatively normal renal function Interactive Cardiovascular and Thoracic Surgery ·Kishore Doddakula, Nael Al-Sarraf, Kathy Gately, Lauren Prest, Michael Tolan, Vincent Young, Jerzy Greblicki	2007	54

About Kathy Gately

Kathy Gately is a scholar working on Cancer Research, Oncology, Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Molecular Biology, having authored 79 papers that have together received 1.8k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (22 papers), Lung Cancer Diagnosis and Treatment (12 papers), Cancer Mechanisms and Therapy (9 papers), PI3K/AKT/mTOR signaling in cancer (8 papers), Cancer therapeutics and mechanisms (6 papers), Cancer Genomics and Diagnostics (6 papers), Cancer, Hypoxia, and Metabolism (6 papers) and NF-κB Signaling Pathways (6 papers). The work is most often cited by research in Cancer Research (366 citations), Oncology (519 citations), Pulmonary and Respiratory Medicine (515 citations), Molecular Biology (808 citations) and Pathology and Forensic Medicine (197 citations). Kathy Gately has collaborated with scholars based in Ireland, Australia and United Kingdom. Frequent co-authors include Kenneth J. O’Byrne, Susan Heavey, Anne‐Marie Baird, Martin P. Barr, Nael Al-Sarraf, Stephen P. Finn, P. Godwin, Julie Lucey, Sinéad Cuffe and Vincent Young. Their work appears in journals such as Lung Cancer, Journal of Thoracic Oncology, Journal of Clinical Oncology, Cancers and Clinical Lung Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact